Literature DB >> 14439056

Prognostic and therapeutic implications of polyps in metachronous colic carcinoma.

I ROSENTHAL, I D BARONOFSKY.   

Abstract

Entities:  

Keywords:  COLON/neoplasms; POLYPI

Mesh：

Year:  1960        PMID： 14439056     DOI： 10.1001/jama.1960.03020010094010

Source DB:  PubMed          Journal:  J Am Med Assoc        ISSN： 0002-9955


× No keyword cloud information.
  8 in total

1.  The significance of small mucosal polyps of the rectum.

Authors:  J F ARTHUR
Journal:  Proc R Soc Med       Date:  1962-08

2.  Abdomino-Perineal Recto- Sigmoidectomy with Pelvic and Para-Aortic Lymph Node Dissection for Synchronous Anal and Rectal Tumor.

Authors:  Nicolae Bacalbasa; Irina Balescu; Vladislav Brasoveanu
Journal:  Maedica (Buchar)       Date:  2015-09

3.  Clinical analysis of multiple primary malignancies in the digestive system: a hospital-based study.

Authors:  Hui-Yun Cheng; Cheng-Hsin Chu; Wen-Hsiung Chang; Tzu-Chi Hsu; Shee-Chan Lin; Chuan-Chuan Liu; An-Ming Yang; Shou-Chuan Shih
Journal:  World J Gastroenterol       Date:  2005-07-21       Impact factor: 5.742

4.  The significance of multiple adenocarcinomas of the colon and rectum.

Authors:  J E Devitt; L A Roth-Moyo; F N Brown
Journal:  Ann Surg       Date:  1969-03       Impact factor: 12.969

5.  Metachronous carcinoma of the large intestine and intestinal polyps.

Authors:  H J Bussey; M H Wallace; B C Morson
Journal:  Proc R Soc Med       Date:  1967-03

6.  Synchronous and metachronous adenocarcinomas of the large intestine.

Authors:  N Tziris; J Dokmetzioglou; K Giannoulis; I Kesisoglou; K Sapalidis; E Kotidis; O Gambros
Journal:  Hippokratia       Date:  2008-07       Impact factor: 0.471

7.  Synchronous cancer of the colon: a case for more definitive resection in colon cancer.

Authors:  B B Anderson
Journal:  J Natl Med Assoc       Date:  1978-08       Impact factor: 1.798

8.  Synchronous triple carcinoma of the colon and rectum.

Authors:  Chien-Chih Yeh; Sheng-Chuan Hsi; Chih-Pin Chuu; Yung-Hsi Kao
Journal:  World J Surg Oncol       Date:  2013-03-13       Impact factor: 2.754
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.